Ancora Heart

Medical device company pioneering minimally invasive heart failure treatment solutions

placeSan Francisco, California, United States calendar_todayFounded 2001 groups89 employees language ancoraheart.com

Registered entities

Innovation

25 patent families (22 granted) — focus: Human necessities, Textiles & paper; filing pace steady. Cited 16,565 times.

YearFilings
20151
20164
201710
201812
20198
202011
202110
20227
20236
20248
20257
20265

Social engagement

Social engagement: 5.2K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record; lead investors include Sio Capital Management, Sands Capital Ventures, Savitr Capital.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

13 Mar 2025 · Senior Product Development Engineer · Santa Clara

Based on job postings tracked across public sources.

Recent activity

11 Jun 2026
Event
9th annual MonteHeart symposium
11 May 2026
Event
Heart Failure Congress 2026
30 Apr 2026
Partnership
University Clinical Center Nis (Univerzitetski kliniki centar Ni)
Coming soon